Skip to main content
Egyptian Liver Journal

Table 2 clinical presentation of the studied groups

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

 

Cirrhosis group

N=50(%)

HCC group

N=50(%)

Test of significance

Hepatic encephalopathy

8 (16.0)

20 (40.0)

χ2=7.14

p=0.008*

Ascites

17 (34.0)

27 (54.0)

χ2=4.06

p=0.04*

Jaundice

11 (22.0)

26 (52.0)

χ2=9.65

p=0.001*

Hematemesis

26 (52.0)

37 (74.0)

χ2=5.19

p=0.023*

DM

20 (40.0)

18 (36.0)

χ2=0.170

p=0.680

  1. *Statistically significant (if p< 0.05)
Back to article page